Analyst consensus rating
Kiora Pharmaceuticals Analyst Rating: Buy
Direct answer
Kiora Pharmaceuticals's consensus rating is Buy.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.00.
Forecast evidence checked November 14, 2026.
Get free Kiora Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.23
- Average price target
- $12.00
- High price target
- $12.00
- Low price target
- $12.00
- Low target gap
- +875.6%
- Target upside
- +875.6%
- High target gap
- +875.6%
- Target range width
- 0%
- Consensus rating
- Buy
- Analysts
- 1
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Kiora Pharmaceuticals?
Kiora Pharmaceuticals has a verified Buy consensus. The same dataset has an average price target of $12.00.
How far are Kiora Pharmaceuticals's low and high targets from the recorded price?
The low target implies +875.6%, while the high target implies +875.6%.
How many analysts are included in Kiora Pharmaceuticals's consensus?
The verified consensus includes 1 analysts.
How is Kiora Pharmaceuticals's target upside or downside calculated?
The average target of $12.00 is divided by the recorded price of $1.23, then one is subtracted to produce +875.6%. This does not guarantee a future return.
When was Kiora Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.